QA: TENAX THERAPEUTICS INC. in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000034956_2019_TENAX_THERAPEUTICS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0000034956')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000034956, TENAX THERAPEUTICS INC.

  xvar xval
0 AssetsCurrent 13,320,240
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 8,525
3 remainder_Assets 8,435
4 LiabilitiesCurrent 1,565,669
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,653,980
9 ResearchAndDevelopmentExpense 1,239,300
10 remainder_Expenses 7,330,604
11 remainder_Revenues 0
12 remainder_NetIncome 79,835
13 remainder_ComprehensiveNetIncome 28,271,389
  yvar yval
0 Assets 13,337,200
1 Liabilities 1,565,669
2 Expenses 14,223,884
3 Revenues 0
4 StockholdersEquity 11,771,531
5 NetIncome -14,144,049
6 ComprehensiveNetIncome -8,354
7 BaseVar 28,738,988
8 EconomicCapitalRatio 2.72

Edgar->Model Mapping

Feature Distribution

Change over Time